Abstract
Purpose
To assess continence and erectile function (EF) recovery of extended pelvic lymph node dissection (ePLND) versus limited PLND (lPLND) after bilateral nerve-sparing radical prostatectomy (BNSRP).
Methods
Consecutive prostate cancer (PCa) patients undergoing BNSRP were stratified according to D’Amico into two groups: low-risk-PCa lPLND (obturator) and intermediate-/high-risk-PCa ePLND (obturator, external iliac artery, internal iliac artery, common iliac artery). Continence (no pad/one safety pad) and EF (IIEF-5 ≥ 17) recovery were assessed. Patients with phosphodiesterase type 5 inhibitors, neoadjuvant/adjuvant therapy, positive lymph nodes or positive surgical margins were excluded.
Results
From January 2007 to May 2012, a total 966 consecutive patients were included. Four hundred and sixty patients met the inclusion/exclusion criteria: 262 patients had ePLND and 198 patients had lPLND. Mean number of lymph nodes was 20.4 (range 10–65) and 4.7 (range 0–10), respectively (p < 0.001). Continence and spontaneous EF recovery after 12 months were 89.7 versus 93.4 % and 40.4 versus 47.5 %, respectively (all p > 0.05). Patient age at surgery (p = 0.001), preoperative EF (p < 0.001) and pathological tumor stage (p = 0.008), but not ePLND (p = 0.561), were independent predictors of EF recovery. No association was detected for continence recovery. Seven-year BCR-free survival for pT2 PCa was 100 and 94.8 % in lPLND and ePLND, respectively (p = 0.011). For pT3 PCa, this was 94.7 and 81.2 %, respectively (p = 0.287). At 2 years, the trifecta of continence, potency and recurrence freedom was achieved in 47.5 and 44.1 % in lPLND and ePLND, respectively (p = 0.451).
Conclusions
ePLND is not associated with increased risk of postoperative incontinence or erectile dysfunction. Only patient age at surgery, preoperative EF and pathological tumor stage represent predictors of EF recovery.
Similar content being viewed by others
References
Khoder W, Waidelich R, Seitz M et al (2015) Do we need the nerve sparing radical prostatectomy techniques (intrafascial vs. interfascial) in men with erectile dysfunction? Results of a single-centre study. World J Urol 33:301–307
Xylinas E, Ploussard G, Durand X et al (2010) Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control—a literature review. Urology 76:1194–1198
Tasci A, Tufek I, Gumus E et al (2014) Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients. World J Urol. doi:10.1007/s00345-014-1393-3
D’Amico A, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974
Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 65:124–137
Gandaglia G, Suardi N, Gallina A et al (2012) Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy. J Sex Med 9:2187–2194
Ledezma R, Negron E, Razmaria AA et al (2015) Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes. World J Urol. doi:10.1007/s00345-015-1515-6
Bivalacqua T, Pierorazio PM, Gorin MA et al (2013) Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology 82:653–659
Passoni N, Abdollah F, Suardi N et al (2014) Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Urol Oncol 32:21–28
Ficarra V, Novara G, Ahlering TE et al (2012) Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 62:418–430
Sagalovich D, Calaway A, Srivastava A, Sooriakumaran P, Tewari AK (2012) Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes. BJU Int 111:85–94
Pettenati C, Neuzillet Y, Radulescu C, Hervé JM, Molinié V, Lebret T (2015) Positive surgical margins after radical prostatectomy: What should we care about? World J Urol. doi:10.1007/s00345-015-1580-x
Michl U, Molfenter F, Graefen M et al (2015) Use of PDE5-inhibitors may adversely impact biochemical recurrence following radical prostatectomy. J Urol 193:479–483
Mattei A, Battista di Piero G, Grande P, Beutler J, Danuser H et al (2013) Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the Monoblock technique. Urology 81:446–450
Ludwig W, Tewari A (2013) Retraction of external iliac vessels and obturator nerve with the vas deferens during extended pelvic lymph node dissection in robot-assisted radical prostatectomy. Urology 81:1369–1371
Park J, Yoo DS, Song C, Park S, Park S, Kim SC, Cho Y, Ahn H et al (2014) Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol 32:193–199
Karl A, Buchner A, Tympner C et al (2015) The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence. World J Urol. doi:10.1007/s00345-015-1510-y
Pokala N, Trulson JJ, Islam M (2014) Long-term outcome following radical prostatectomy for Gleason 8–10 prostatic adenocarcinoma. World J Urol 32:1385–1392
Billia M, Elhage O, Challacombe B et al (2014) Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years. World J Urol 32:413–418
Novara G, Ficarra V, D’Elia C, Secco S, Cavalleri S, Artibani W (2010) Trifecta outcomes after robot-assisted radical prostatectomy. BJU Int 107:100–104
Lavery H, Nabizada-Pace F, Carlussi JR, Brajtbord JS, Samadi DB (2012) Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious. Urol Oncol 30:26–32
Briganti A, Capitanio U, Chun FK, Karakiewicz PI, Salonia A, Bianchi M, Cestari A, Guazzoni G, Rigatti P, Montorsi F et al (2009) Prediction of sexual function after radical prostatectomy. Cancer 115:150–159
Tewari A, Sooriakumaran P, Bloch DA, Seshadri-Kreaden U, Hebert AE, Wiklund P et al (2012) Positive surgical margin and perioperative complications rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62:1–15
Nitti V, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group (2014) Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol 192:836–842
Suardi N, Moschini M, Gallina A et al (2012) Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int 111:717–722
Jeong S, Yeon JS, Lee JK et al (2014) Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence. World J Urol 32:437–444
Authors’ contribution
G. Hatzichristodoulou involved in project development, data collection and management and data analysis and wrote the manuscript. S. Wagenpfeil and G. Wagenpfeil involved in data analysis. T. Maurer, T. Horn, K. Herkommer and M. Hegemann involved in data collection. J. Gschwend and H. Kübler edited the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Hatzichristodoulou, G., Wagenpfeil, S., Wagenpfeil, G. et al. Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis. World J Urol 34, 811–820 (2016). https://doi.org/10.1007/s00345-015-1699-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1699-9